MedPath

Assessing the binding interaction of polystyrene sulfonate with amitriptyline in healthy volunteers;The BIND-study

Phase 4
Completed
Conditions
betreft interactiestudie in gezonde vrijwilligers.
drug-drug interaction study
Registration Number
NL-OMON49827
Lead Sponsor
Deventer Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
9
Inclusion Criteria

- The participant is at least 18 years of age

Exclusion Criteria

- Known allergy to one of the investigated substances
- Known renal or hepatic impairment
- Pregnancy
- Breast feeding
- Use of other medication within 24 hours of the study period (oral
contraceptives within 12 hours of the study period)
- Contra-indication for one of the investigated substances (such as recent
myocardial infarction, cardiac arrhythmias, hypokalaemia and obstructive bowl
disease)
- History of a gastro-intestinal condition that may interfere with absorption
of amitriptyline

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Difference in exposure of amitriptyline in the presence and absence of<br /><br>polystyrene sulfonate, expressed in Cmax and AUC0-8h.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath